CAYUGA BIOTECH

cayuga-biotech-logo

Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.

#People #Financial #Event #Website #More

CAYUGA BIOTECH

Industry:
Biotechnology Health Care Medical Medical Device

Founded:
2015-01-01

Address:
Bridgewater, New Jersey, United States

Country:
United States

Website Url:
http://www.cayugabiotech.com

Total Employee:
11+

Status:
Active

Total Funding:
250 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Mobile Non Scaleable Content Google Apps For Business


Current Employees Featured

damien-kudela_image

Damien Kudela
Damien Kudela Co-Founder and CSO @ Cayuga Biotech
Co-Founder and CSO
2014-01-01

kyle-ploense_image

Kyle Ploense
Kyle Ploense Head of Research & Development, CTO @ Cayuga Biotech
Head of Research & Development, CTO
2015-05-01

not_available_image

Andrea Ashford-Hicks
Andrea Ashford-Hicks Chief Executive Officer @ Cayuga Biotech
Chief Executive Officer
2022-02-01

Founder


damien-kudela_image

Damien Kudela

kyle-ploense_image

Kyle Ploense

Investors List

sosv_image

SOSV

SOSV investment in Seed Round - Cayuga Biotech

synbio-axlr8r_image

IndieBio

IndieBio investment in Seed Round - Cayuga Biotech

sosv_image

SOSV

SOSV investment in Convertible Note - Cayuga Biotech

synbio-axlr8r_image

IndieBio

IndieBio investment in Convertible Note - Cayuga Biotech

synbio-axlr8r_image

IndieBio

IndieBio investment in Seed Round - Cayuga Biotech

sosv_image

SOSV

SOSV investment in Seed Round - Cayuga Biotech

Key Employee Changes

Date New article
2022-03-03 Cayuga Biotech Appoints Andrea Ashford-Hicks as Chief Executive Officer

Official Site Inspections

http://www.cayugabiotech.com

  • Host name: premium80-5.web-hosting.com
  • IP address: 199.188.200.253
  • Location: Los Angeles United States
  • Latitude: 34.0318
  • Longitude: -118.4252
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90064

Loading ...

More informations about "Cayuga Biotech"

About Us | Cayuga Biotech - Innovators in Hemorrhage Control

Discover Cayuga Biotech's dedicated team, groundbreaking science, and visionary leadership driving innovation in hemorrhage control and bleeding disorder treatments. Learn about our โ€ฆSee details»

Innovative Hemorrhage Control Solutions | Cayuga โ€ฆ

References: Cannon 2018, Eastridge et al 2019, Gimbel et al 2018, Kelly et al 2008, ClinCalc Drug Usage Statistics 2020See details»

Cayuga Biotech - Crunchbase Company Profile & Funding

Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries.See details»

Cayuga Biotech - LinkedIn

#CayugaBiotech will be presenting data for its first generation, first-in-class, #polyphosphate-based therapy at the 66th American Society of #Hematology Annual Meeting and Exposition in San Diego ...See details»

Cayuga Biotech 2025 Company Profile: Valuation, โ€ฆ

Www.cayugabiotech.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 500 8th Avenue Front 3; Suite 1596; New York, NY 10018; United StatesSee details»

Cayuga Biotech, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Cayuga Biotech, Inc. of Basking Ridge, NJ. Get the latest business insights from Dun & Bradstreet.See details»

Cayuga - Crunchbase Company Profile & Funding

We research novel hemostatic drugs. Cayuga develops novel hemostatic drugs and devices using biomimetic polyphosphate technology to control bleeding and accelerate healing.See details»

Cayuga Biotech Company Profile | Management and Employees โ€ฆ

Find contact information for Cayuga Biotech. Learn about their Research & Development, Business Services market share, competitors, and Cayuga Biotech's email format.See details»

Cayuga Biotech - Company Profile & Staff Directory - ContactOut

Cayuga Biotech is an early-stage platform biotechnology company harnessing the body's innate ability to halt bleeding and heal. Cayuga's core proprietary technology leverages a recently โ€ฆSee details»

Cayuga Biotech, Inc. - Drug pipelines, Patents, Clinical โ€ฆ

To learn more, please visit www.CayugaBiotech.com . Clinical Result. 26 Jun 2024 ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into โ€ฆSee details»

Cayuga Biotech - Products, Competitors, Financials, Employees ...

NuFund was formerly known as Tech Coast Angels โ€“ San Diego (TCA-SD), and the organization is one of the largest, most active, and most successful early-stage investor groups over the โ€ฆSee details»

NuFund Venture Group Celebrates Cayuga Biotechโ€™s โ€ฆ

Dec 9, 2024 To learn more, please visit www.CayugaBiotech.com. About NuFund Venture Group NuFund Venture Group represents a new wave of angel investors, pioneering a novel โ€ฆSee details»

Cayuga Biotech Information - RocketReach

Cayuga is developing novel biomimetic therapies leveraging inorganic polyphosphate, a polymer that modulates the healing response. The company has an optimized polyP-SNP complex in โ€ฆSee details»

Join Us in Transforming Hemorrhage Care - Cayuga Biotech

If you are interested in investment, development, licensing or other partnership discussions, we invite you to get in touch at [email protected] 500 Eighth Avenue, Front 3, # 1596 โ€ฆSee details»

Cayuga Biotech - IndieBio - #1 in Early Stage Biotech

Cayugabiotech.com * Data source: Crunchbase. Damien Kudela, Ph.D., CEO. Bleeding causes a lot of negative outcomes for patients, so stopping the bleeding has many benefits. Not only are โ€ฆSee details»

Cayuga Biotech - Extreme Tech Challenge

Blood loss is the leading cause of preventable death, causing nearly 2 million deaths per year among both civilians and military personnel. Cayuga Biotech aims to create a solution by โ€ฆSee details»

NuFund Venture Group Celebrates Cayuga Biotechโ€™s โ€ฆ

Dec 9, 2024 To learn more, please visit www.CayugaBiotech.com. About NuFund Venture Group. NuFund Venture Group represents a new wave of angel investors, pioneering a novel โ€ฆSee details»

Cayuga Biotech - VentureRadar

Similar Companies: Cardurion Pharma USA Privately Held Cardurion, a Boston-based, clinical-stage cardiovascular biotechnology company, is developing novel, next-generation โ€ฆSee details»

Cayuga Biotech - Overview, News & Similar companies - ZoomInfo

Cayuga Biotech contact info: Phone number: (908) 938-1792 Website: www.cayugabiotech.com What does Cayuga Biotech do? Cayuga Biotech is an early-stage platform biotechnology โ€ฆSee details»

Our Science | Cayuga Biotech - Revolutionizing Hemorrhage Control

Discover how Cayuga Biotech's innovative science leverages natural polymers to enhance clotting and improve hemorrhage outcomes. Learn about our groundbreaking CAY001 โ€ฆSee details»

linkstock.net © 2022. All rights reserved